Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.

Saved in:
Bibliographic Details
Title: Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial.
Authors: Huebner, G.1 lghuebner@web.de, Link, H.1, Kohne, C. H.2, Stahl, M.3, Kretzschmar, A.4, Steinbach, S.1, Folprecht, G.2, Bernhard, H.5, Al-Batran, S. E.6, Schoffski, P.7, Burkart, C.8, Kullmann, F.9, Otremba, B.10, Menges, M.11, Hoffmann, M.12, Kaiser, U.13, Aldaoud, A.14, Jahn, A.15, German CUP Study Group (CORPORATE AUTHOR)
Source: British Journal of Cancer. 1/13/2009, Vol. 100 Issue 1, p44-49. 6p. 1 Diagram, 3 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6604818